JK

Jayan Karthanam Veedu

Active Director Director DIN 07765014
DIN 07765014 First appointment Aug 2017 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Jayan Karthanam Veedu

Data last updated:

Jayan Karthanam Veedu is a Director at Agueda Pharmaceuticals Private Limited (since 2017). The company operates in Business Services.

DIN 07765014
Primary Designation Director
Industry Business Services
First Appointment 17 Aug 2017
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Aug 20172017Active

Directorship timeline

Open interactive timeline →
Agueda Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jayan Karthanam Veedu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jayan Karthanam Veedu

Jayan Karthanam Veedu currently holds 1 directorship: Agueda Pharmaceuticals Private Limited (Director, since 17 Aug 2017).

Jayan Karthanam Veedu was first appointed on 17 Aug 2017 as Director at Agueda Pharmaceuticals Private Limited.

The current boards of Jayan Karthanam Veedu's companies include Anirudhan Kadamkuni (Agueda Pharmaceuticals Private Limited), Ganesh Babu Kizhake Veetil (Agueda Pharmaceuticals Private Limited), Nasar Kuchanath House (Agueda Pharmaceuticals Private Limited), Sreevidya Poyil Narayanan (Agueda Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available